Progressive supranuclear palsy

We’re all in this for good.

By sharing your stories and data, you will:
  • help each other live better and uncover the best ways to manage your health today
  • help researchers shorten the path to new treatments tomorrow

How much good can your data do? A whole lot, as co-founder Jamie Heywood explains in this video.

What is progressive supranuclear palsy?

Progressive supranuclear palsy is a rare neurodegenerative disorder characterized by gait and balance difficulties and loss of coordination of eye movements.

Common symptoms reported by people with progressive supranuclear palsy

Common symptoms
How bad it is
What people are taking for it

Reports may be affected by other conditions and/or medication side effects. We ask about general symptoms (anxious mood, depressed mood, fatigue, pain, and stress) regardless of condition.
Last updated:

Treatments taken by people with progressive supranuclear palsy

Treatment name(s)
Type
How many have tried
Tried for
Treatment name(s)

(Sinemet)
Type
Prescription Drug
How many have tried
1
Treatment name(s)

(Lunasin Duke Virtual Trial)
Type
Supplement
How many have tried
1

Data from patients with progressive supranuclear palsy, who reported starting treatments within the last 5 years.
Last updated:

Compare treatments taken by people with progressive supranuclear palsy

Treatment name(s)
Perceived effectiveness
Side effects
Total evaluations
Tried for
Treatment name(s)

(Sinemet)
Perceived effectiveness
for progressive supranuclear palsy (2 evaluations)
Side effects
falls
Total evaluations
2
Treatment name(s)

(Lunasin Duke Virtual Trial)
Perceived effectiveness
for progressive supranuclear palsy (1 evaluation)
Side effects
Total evaluations
2
  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
  • Severe
  • Moderate
  • Mild
  • None

Data from patients with progressive supranuclear palsy, who reported starting treatments within the last 5 years.
Last updated:

Who has progressive supranuclear palsy on PatientsLikeMe?


Age
Age Proportion # of patients
<20 0
20s 0
30s 9
40s 5
50s 24
60s 55
70+ 117
Age at first symptom
Age at first symptom Proportion # of patients
0-19 years 1
20-29 years 0
30-39 years 4
40-49 years 8
50-59 years 20
60-69 years 31
70+ years 14

Distribution of sex

Sex
Sex Proportion # of patients
Male 103
Female 109

Types
Condition Types Proportion # of patients
Corticobasal degeneration (CBD) 16
Progressive supranuclear palsy (PSP/Steele Richardson Olszewski Syndrome) 130
Diagnosis status
Diagnosis status Proportion # of patients
Diagnosed 86
Not Diagnosed 20

These charts show data from PSP patients who have completed their condition history
Last updated: